Serum levels of hsa‐miR‐16‐5p, hsa‐miR‐29a‐3p, hsa‐miR‐150‐5p, hsa‐miR‐155‐5p and hsa‐miR‐223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC studychronic lymphocytic leukemiacirculating miRNAserumprospective study...
Using a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC), the predictive values of five promising human miRNAs ( hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR‐223‐3p ), identified in ...
hsa‐miR‐155‐5p and hsa‐miR‐29a‐3p was associated with subsequent risk of CLL [ OR 1Ct‐unit increase (95%CI) = 1.42 (1.18–1.72), 1.64 (1.31–2.04) and 1.75 (1.31–2.34) for hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 29a‐3p , respectively] and the strongest...